Sofosbuvir and Thin bones - a phase IV clinical study of FDA data
Summary:
Thin bones is reported as a side effect among people who take Sofosbuvir (sofosbuvir), especially for people who are female, 50-59 old, also take Dolutegravir, and have Hepatitis c.
The phase IV clinical study analyzes which people have Thin bones when taking Sofosbuvir. It is created by eHealthMe based on reports of 9,193 people who have side effects when taking Sofosbuvir from the FDA, and is updated regularly.
What is Sofosbuvir?
Sofosbuvir has active ingredients of sofosbuvir. eHealthMe is studying from 9,194 Sofosbuvir users. Check the latest studies of Sofosbuvir.
What is Thin bones?
Thin bones is found to be associated with 2,427 drugs and 1,925 conditions by eHealthMe. Check the latest studies of Thin bones.
9,193 people reported to have side effects when taking Sofosbuvir.
Among them, 19 people (0.21%) have Thin bones.

Among these 19 people:
What is the gender of people who have Thin bones when taking Sofosbuvir? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Thin bones when taking Sofosbuvir? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 15.79 %
- 50-59: 84.21 %
- 60+: 0.0 %
What are other drugs people take besides Sofosbuvir? *
- Dolutegravir: 17 people, 89.47%
- Descovy: 13 people, 68.42%
- Truvada: 12 people, 63.16%
- Harvoni: 12 people, 63.16%
- Emtricitabine: 2 people, 10.53%
- Ibandronate Sodium: 1 person, 5.26%
- Hydrea: 1 person, 5.26%
- Exjade: 1 person, 5.26%
- Desferal: 1 person, 5.26%
- Daklinza: 1 person, 5.26%
What are other side effects people have besides Thin bones? *
- Foot Fracture: 17 people, 89.47%
- Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 15 people, 78.95%
- Hepatitis C: 15 people, 78.95%
- Drug Resistance (reduction in effectiveness of a drug): 15 people, 78.95%
- Throat Irritation: 2 people, 10.53%
- Hand Fracture: 2 people, 10.53%
- Haemoglobin Decreased: 1 person, 5.26%
- Hepatic Steatosis (fatty liver disease): 1 person, 5.26%
- Hepatic Pain (pain in liver): 1 person, 5.26%
- Hepatic Enzyme Increased: 1 person, 5.26%
What are the existing conditions these people have? *
- Hepatitis C: 19 people, 100.00%
- Hiv Infection: 17 people, 89.47%
- Liver Disorder (liver diseases): 1 person, 5.26%
- Iron Overload: 1 person, 5.26%
- Anaemia (lack of blood): 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Sofosbuvir and have Thin bones?
- Check whether Thin bones is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sofosbuvir:
- Sofosbuvir (9,194 reports)
Thin bones treatments and more:
- Thin bones (290,733 reports)
How severe was Thin bones and when was it recovered:
Expand to all the drugs that have ingredients of sofosbuvir:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sofosbuvir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Thin bones:
- Thin bones (2,427 drugs)
Browse all the conditions that are associated with Thin bones:
- Thin bones (1,925 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sofosbuvir) and Sofosbuvir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Niacin and Magnesium Citrate - 4 seconds ago
- Drug interactions of Lansoprazole and Atropa Belladonna - 8 seconds ago
- Drug interactions of Metolazone and Prohance - 13 seconds ago
- Raspberry Ketone vs. Bee Pollen, side effect and effectiveness comparison - 17 seconds ago
- Xeljanz and Itchiness for Women aged 60+ - 28 seconds ago
- Xeljanz and Pruritus for Women aged 60+ - 29 seconds ago
- Xeljanz and Itching for Women aged 60+ - 29 seconds ago
- Drug interactions of Ganciclovir and Viread - 33 seconds ago
- Drug interactions of Hydrocodone and Provera - 35 seconds ago
- Could Phenazopyridine Hcl Tab cause Band Neutrophil Count Increased? - 36 seconds ago